Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro

Invest Ophthalmol Vis Sci. 2012 Sep 19;53(10):6305-13. doi: 10.1167/iovs.12-9828.

Abstract

Purpose: To evaluate the disinfectant effect of methylene blue (MB)-mediated photodynamic therapy (PDT) on a pathogenic strain of Acanthamoeba.

Methods: Acanthamoeba castellanii (ATCC 50370) used in this study were treated under one of four experimental conditions: light irradiation and incubation in MB (L+M+), light irradiation and incubation in physiologic solution (L+M-), incubation in MB only (L-M+), and incubation in physiologic solution (L-M-). M+ trophozoites were incubated in either 0.25 or 0.5 mM MB for 10 minutes. L+ organisms were irradiated for 30 minutes following incubation in solution. A halogen lamp (660 ± 10 nm) with a maximum output of 6 mW/cm(2) was used as the PDT light source. After treatment, antiacanthamoeba activity was evaluated by checking the respiratory activity of the amoeba with 5-cyano-2,3-tetrazolium chloride (CTC) staining. We also determined whether the effect of PDT with MB had been retained or augmented when it was performed in combination with conventional antiamoebic agents.

Results: MB-PDT suppressed the respiratory activity of trophozoites in an MB-concentration-dependent manner at total light doses of 10.8 J/cm(2). The respiratory activity of each group as a percentage of that of L-M- is as follows: L+M+ 11.6% (0.5 mM), 60.9% (0.25 mM); L-M+ 116.5% (0.5 mM), 105.5% (0.25 mM); L+M- 107.6%; and L-M- 106.3%. (L+M+ versus L-M- P < 0.05). MB-PDT had a synergistic effect when used in combination with polyhexamethylene biguanide (PHMB) or amphotericin B, but not with voriconazole.

Conclusions: MB-PDT is effective against Acanthamoeba in vitro and has synergistic effects with PHMB and amphotericin B.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acanthamoeba castellanii / drug effects*
  • Acanthamoeba castellanii / growth & development*
  • Amebiasis / drug therapy
  • Amebicides / pharmacology
  • Amphotericin B / pharmacology
  • Animals
  • Antifungal Agents / pharmacology
  • Drug Therapy, Combination
  • Enzyme Inhibitors / pharmacology
  • Guanidines / pharmacology
  • Humans
  • In Vitro Techniques
  • Keratitis / drug therapy
  • Keratitis / parasitology
  • Methylene Blue / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Photochemotherapy / methods*
  • Photosensitizing Agents / pharmacology
  • Polymers / pharmacology
  • Pyrimidines / pharmacology
  • Riboflavin / pharmacology
  • Triazoles / pharmacology
  • Ultraviolet Therapy / methods
  • Voriconazole

Substances

  • Amebicides
  • Antifungal Agents
  • Enzyme Inhibitors
  • Guanidines
  • Photosensitizing Agents
  • Polymers
  • Pyrimidines
  • Triazoles
  • poly(hexamethylenebiguanidinium)
  • Amphotericin B
  • Voriconazole
  • Methylene Blue
  • Riboflavin